Cipla Limited has informed the Exchange regarding Appointment of Ms Joshi Apte & Associates as Cost Auditors of the company w.e.f. April 01, 2026.
CIPLA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Cipla Limited's Board of Directors met on May 13, 2026, and approved four key items. First, the 90th Annual General Meeting is scheduled for June 25, 2026. Second, the company granted stock options and Employee Stock Appreciation Rights (ESARs) totaling around 7.72 lakh units under existing employee benefit schemes. Third, M/s Joshi Apte & Associates has been appointed as Cost Auditors for FY 2026-27, effective April 1, 2026. Fourth, Mr Sushrut Kulkarni has been appointed as President & Global Chief – Integrated Product Development, joining the Management Council and Senior Management Personnel effective May 18, 2026. Mr Kulkarni brings over three decades of experience from Dr Reddy's Laboratories, Glenmark, and Zydus.
The appointment of a new Cost Auditor is routine and expected to have minimal impact on stock price. The hiring of an experienced executive like Mr Kulkarni for a critical R&D leadership role could be viewed positively by investors as it strengthens the company's product development capabilities.